首页> 美国卫生研究院文献>Molecular Endocrinology >cGMP Inhibits TGF-β Signaling by Sequestering Smad3 with Cytosolic β2-Tubulin in Pulmonary Artery Smooth Muscle Cells
【2h】

cGMP Inhibits TGF-β Signaling by Sequestering Smad3 with Cytosolic β2-Tubulin in Pulmonary Artery Smooth Muscle Cells

机译:cGMP通过将Smad3与胞质β2-微管蛋白螯合在肺动脉平滑肌细胞中抑制TGF-β信号传导

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Atrial natriuretic peptide (ANP) and TGF-β play counterregulatory roles in pulmonary vascular adaptation to chronic hypoxia. We have demonstrated that ANP-cyclic GMP (cGMP)-protein kinase G (PKG) signaling inhibits TGF-β signaling by blocking TGF-β-induced nuclear translocation of mothers against decapentaplegic homolog (Smad)3 in pulmonary artery smooth muscle cells (PASMC). The current study tested the novel hypothesis that activation of the ANP-cGMP-PKG pathway limits TGF-β-induced Smad3 nuclear translocation by enhancing Smad3 binding to cytosolic anchoring proteins in isolated pulmonary artery smooth muscle cells. Cells were pretreated with vehicle or cGMP and then exposed to TGF-β1 treatment. Cytosolic fractions were isolated and immunoprecipitated with a selective anti-Smad3 antibody. Differential proteomic analysis of the cytosolic Smad3-interacting proteins by two-dimensional differential in-gel electrophoresis and mass spectroscopy followed by coimmunoprecipitation and immunostaining demonstrated that Smad3 was bound to β2-tubulin in a TGF-β1/cGMP-dependent manner: binding of Smad3 to β2-tubulin was decreased by TGF-β1 and increased by cGMP treatment. A site-directed mutagenesis study demonstrated that mutating Smad3 at Thr388, but not Ser309, two potential sites of PKG-induced hyperphosphorylation, inhibited cGMP-induced Smad3 binding to β2-tubulin. Further, luciferase reporter analysis showed that muation of T388 in Smad3 abolished the inhibitory effect of cGMP on TGF-β1-induced plasminogen activator inhibitor-1 (PAI-1) transcription. In addition, disruption of β2-tubulin with the microtubule depolymerizers nocodazole and colchicine promoted Smad3 dissociation from β2-tubulin, increased both TGF-β1-induced Smad3 nuclear translocation and PAI-1 mRNA expression, and abolished the inhibitory effects of cGMP on these processes. In contrast, the microtubule stabilizers paclitaxel and epothilone B increased cytosolic Smad3 binding to β2-tubulin and enhanced the inhibitory effect of cGMP on Smad3 nuclear translocation and PAI-1 expression in response to TGF-β1. These provocative findings suggest that sequestering Smad3 by β2-tubulin in cytosol is a key mechanism by which ANP-cGMP-PKG signaling interferes with downstream signaling from TGF-β and thus protects against pulmonary arterial remodeling in response to hypoxia stress.
机译:心钠素和TGF-β在肺血管对慢性低氧的适应中起反调节作用。我们已经证明,ANP环GMP(cGMP)-蛋白激酶G(PKG)信号通过阻断TGF-β诱导的母亲针对肺动脉平滑肌细胞(CAPMC)中的去甲肾上腺素能同系物(Smad)3抑制母亲的核易位,从而抑制TGF-β信号。 )。当前的研究检验了新的假设,即ANP-cGMP-PKG途径的激活通过增强Smad3与分离的肺动脉平滑肌细胞中胞浆锚定蛋白的结合来限制TGF-β诱导的Smad3核易位。细胞用媒介物或cGMP预处理,然后暴露于TGF-β1处理。分离细胞溶质级分,并用选择性抗Smad3抗体免疫沉淀。通过二维差异凝胶电泳和质谱,然后进行免疫共沉淀和免疫染色,对胞质Smad3相互作用蛋白进行差异蛋白质组学分析,结果表明Smad3以TGF-β1/ cGMP依赖性方式与β2-微管蛋白结合:Smad3的结合TGF-β1可降低β2-微管蛋白的表达,cGMP处理可提高β2-微管蛋白的表达。一项定点诱变研究表明,在Thr388突变Smad3,而不在Ser309突变,这两个PKG诱导的过度磷酸化的潜在位点,抑制了cGMP诱导的Smad3与β2-微管蛋白的结合。此外,荧光素酶报告基因分析表明,Smad3中的T388突变消除了cGMP对TGF-β1诱导的纤溶酶原激活物抑制剂1(PAI-1)转录的抑制作用。此外,用微管解聚剂诺考达唑和秋水仙碱破坏β2-微管蛋白可促进Smad3从β2-微管蛋白解离,同时增加TGF-β1诱导的Smad3核易位和PAI-1 mRNA表达,并消除了cGMP对这些过程的抑制作用。相反,微管稳定剂紫杉醇和埃博霉素B增强了胞浆Smad3与β2-微管蛋白的结合,并增强了cGMP对Smad3核易位和PAI-1表达的抑制作用,以响应TGF-β1。这些具有启发性的发现表明,胞浆中的β2-微管蛋白螯合Smad3是ANP-cGMP-PKG信号传导干扰TGF-β下游信号传导的关键机制,因此可防止缺氧应激引起的肺动脉重构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号